IN187541B - - Google Patents

Info

Publication number
IN187541B
IN187541B IN1387CA1995A IN187541B IN 187541 B IN187541 B IN 187541B IN 1387CA1995 A IN1387CA1995 A IN 1387CA1995A IN 187541 B IN187541 B IN 187541B
Authority
IN
India
Application number
Inventor
Robert Edward Zelle
Matthew William Harding
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/377,285 external-priority patent/US5543423A/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of IN187541B publication Critical patent/IN187541B/en

Links

IN1387CA1995 1995-01-23 1995-11-03 IN187541B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/377,285 US5543423A (en) 1994-11-16 1995-01-23 Amino acid derivatives with improved multi-drug resistance activity

Publications (1)

Publication Number Publication Date
IN187541B true IN187541B (en) 2002-05-18

Family

ID=29711919

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1387CA1995 IN187541B (en) 1995-01-23 1995-11-03

Country Status (1)

Country Link
IN (1) IN187541B (en)

Similar Documents

Publication Publication Date Title
DE69638352D1 (en)
DE69637714D1 (en)
BR122012014331A2 (en)
BRPI9612258B1 (en)
BRPI9612138B1 (en)
CH0741373H1 (en)
DK0727898T3 (en)
IN187541B (en)
AU1627395A (en)
BR7501503U (en)
BR7502120U (en)
DK126096A (en)
CN3032522S (en)
CN3034473S (en)
CN3030489S (en)
CN3030542S (en)
CN3030543S (en)
CN3031001S (en)
CN3031350S (en)
CN3031655S (en)
CN3031742S (en)
CN3031926S (en)
CN3032332S (en)
CN3032390S (en)
CN3030296S (en)